Use of reagent for detecting QRSL1 protein in preparation of diagnostic reagent, and neoadjuvant immunotherapy resistance in locally advanced esophageal squamous cell carcinoma, where patient resistance to neoadjuvant immunotherapy regimen includes immune checkpoint inhibitor and chemotherapy drug